ResMed Inc. (FRA:RME)

Market Cap	32.04B -6.3%
Revenue (ttm)	4.60B +9.6%
Net Income	1.27B +19.0%
EPS	8.61 +19.4%
Shares Out	n/a
PE Ratio	25.32
Forward PE	22.29
Dividend	2.00 (0.93%)
Ex-Dividend Date	Feb 12, 2026

Volume	n/a
Average Volume	13
Open	217.30
Previous Close	219.50
Day's Range	216.40 - 217.30
52-Week Range	180.20 - 250.20
Beta	n/a
RSI	49.76
Earnings Date	Jan 29, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RME

Financial Performance

In fiscal year 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD